Innovating for Patients

Patients inspire and motivate our science. Our ever-growing knowledge of the causes of many chronic, rare and prevalent diseases is driving the development of potential new treatment options derived both from our expertise in human plasma as well as a new class of recombinant antibody drugs and small-molecule candidates. We probe deeply into a range of pathologies – from immunodeficiencies to respiratory disorders to age-related conditions – to create innovative therapeutics that adhere to the highest scientific, ethical and quality standards to help improve people’s lives.

Key Therapeutic Areas

Grifols treatments center on immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. Each area features therapies helping patients today as well as boundary-pushing research leading to the next groundbreaking discoveries. The next wave of Grifols innovation has the potential to significantly transform healthcare.

Grifols innovation at work


billion investment in innovation

in the last 6 years




R+D+i centers

Connecting Knowledge – Our R&D Network

Our global network of three innovation hubs is home to more than 1,200 investigators working on everything from early discovery to advanced clinical trials.